Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Kilitch Company Pharma Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201120-09-2012
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Kilitch Company Pharma Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
NBZ Pharma Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
NBZ Pharma Ltd has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSEDisclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Kilitch Company (Pharma) Ltd has submitted the disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011Fixes Record Date for Special Interim Dividend
Kilitch Drugs India Ltd has informed BSE that September 25, 2012 has been fixed as the Record Date for the purpose of Payment of Special Interim Dividend.Board declares Special Interim Dividend (AGM on Sep 29, 2012)
Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 30, 2012, inter alia, 1. Declared Special Interim dividend @ 300% (i.e. Rs.30/- per equity share of Rs.10/- each) on the equity shares of the Company.2. Decided to convene the 20th Annual General Meeting of the Members of.the Company at the Registered Office of the Company at C-301/2. MIDC, TTC Industrial Area, Pawane...Board to consider Special Interim Dividend
Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 30, 2012, inter alia, to consider the following business:1. To recommend Special Interim Dividend on equity shares of the Company;2. To fix the record date for the purpose of Special Interim Dividend;3. To take on record the Audited Consolidated Financial Results of the Company for the year ended March 31, 2012;...Financial Results & Limited Review for June 30, 2012
Kilitch Drugs India Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2012.Limited Review for March 31, 2012
Kilitch Drugs India Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended March 31, 2012.Financial Results for March 31, 2012
Kilitch Drugs India Ltd has informed BSE about the Financial Results for the period ended March 31, 2012.